JCR Pharmaceuticals and Modalis Therapeutics Announce Transition to the Next Phase of Joint Research Agreement for Development of Novel Gene Therapy January 6, 2025 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Coway Named a CES 2025 Innovation Awards Honoree Back: All Posts Next:China's Geely Holding targets over 5 million units of annual sales by 2027